EMEA-000342-PIP01-08-M07

Key facts

Invented name
Sutent
Active substance
sunitinib
Therapeutic area
Oncology
Decision number
P/0147/2018
PIP number
EMEA-000342-PIP01-08-M07
Pharmaceutical form(s)
  • Capsule
  • Capsule (hard)
Condition(s) / indication(s)
Treatment of gastro-intestinal stromal tumours
Route(s) of administration
Oral use
Contact for public enquiries
Pfizer Limited
Tel. +44 (0)1034 646607
E-mail: pip_enquiries@pfizer.com
Decision type
PM: decision on the application for modification of an agreed PIP
Compliance procedure number
EMEA-C-000342-PIP01-08-M07
Compliance opinion date
29/06/2018
Compliance outcome
positive

Decision

How useful was this page?

Add your rating